已收盘 09-06 16:00:00 美东时间
0.000
0.00%
BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.00) per share. This is a 99.85 percent increase over losses of $(2.00) per share from the same period last year.
2023-08-11 21:02
JERUSALEM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceutical...
2023-08-02 04:01
JERUSALEM, ISRAEL / ACCESSWIRE / May 15, 2023 / (via IBN) -- BiondVax Pharmaceu...
2023-05-16 04:45
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Rating) was the recipient of a...
2023-04-18 04:43
BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) and ImmunityBio (NASDAQ:IBR...
2023-04-15 18:23
BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) and ImmunityBio (NASDAQ:IBR...
2023-04-15 18:23
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV...
2023-04-05 13:42
Stock Analysts' new coverage for Friday, March 24th: StockNews.com assumed cove...
2023-03-25 02:54
Stock Analysts' new coverage for Friday, March 24th: StockNews.com assumed cove...
2023-03-25 02:54
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BV...
2023-03-16 21:24